Schonfeld Strategic Advisors’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.65M | Buy |
353,514
+53,775
| +18% | +$860K | 0.04% | 471 |
|
|
2025
Q1 | $4.56M | Buy |
299,739
+1,500
| +0.5% | +$22.8K | 0.03% | 492 |
|
|
2024
Q4 | $6.05M | Buy |
298,239
+100,139
| +51% | +$2.03M | 0.04% | 403 |
|
|
2024
Q3 | $5.09M | Buy |
198,100
+43,669
| +28% | +$1.12M | 0.03% | 441 |
|
|
2024
Q2 | $1.99M | Sell |
154,431
-27,529
| -15% | -$354K | 0.01% | 805 |
|
|
2024
Q1 | $4.17M | Buy |
+181,960
| New | +$4.17M | 0.03% | 598 |
|